Observational studyJournal for immunotherapy of cancer2024

Multicenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the PREDAPT study.

Kevin C Flanagan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.